Oxidative stress and antioxidative potency are closely associated with diabetic retinopathy and nephropathy in patients with type 2 diabetes

Saudi Medical Journal

Volumn 34, Issue 2, 2013, Pages 135-141

  Naruse, Rika ^a   Suetsugu, Mariko ^a   Terasawa, Tomoko ^a   Ito, Keishi ^a   Hara, Kenji ^a   Takebayashi, Kohzo ^a   Morita, Kimio ^a   Aso, Yoshimasa ^a   Inukai, Toshihiko ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTIDIABETIC AGENT; C PEPTIDE; CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROPEROXIDE; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; ANTIOXIDANT;

ADULT; ANKLE BRACHIAL INDEX; ARTICLE; BLOOD PRESSURE; BODY WEIGHT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DIET THERAPY; DISEASE COURSE; ELECTRON SPIN RESONANCE; FEMALE; HUMAN; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PHOTOMETRY; PULSE WAVE; SMOKING; WAIST CIRCUMFERENCE; AGED; CASE CONTROL STUDY; COMPLICATION; METABOLISM; MIDDLE AGED;

ADULT; AGED; ANTIOXIDANTS; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DIABETIC RETINOPATHY; FEMALE; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS;

EID: 84874416762     PISSN: 03795284     EISSN: 16583175     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Esposito K, Ciotola M, Schisano B, Misso L, Giannetti G, Ceriello A, et al. Oxidative stress in the metabolic syndrome. J Endocrinol Invest 2006; 29: 791-795.
2. Mantovaoni C, Maccio A, Madeddu C, Mura L, Massa E, Gramignano G, et al. Reactive oxygen species, antioxidant mechanisms and serum cytokine levels in cancer patients: impact of an antioxidant treatment. J Cell Mol Med 2002; 4: 570-582.
3. Inoguchi T, Li P, Umeda F, Yu HY, Kamimoto M, Imamura M, et al. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 2000; 49: 1939-1945.
4. Nascimento NRF, Lessa LMA, Kerntopf MR, Sousa CM, Alves RS, Queiroz MGR, et al. Inositols prevent and reverse endothelial dysfunction in diabetic rat and rabbit vasculature metabolically and by scavenging superoxide. Proc Natl Acad Sci USA 2006; 103: 218-223.
5. Sciascia S, Roccatello D, Bertero MT, Di Simone D, Cosseddu D, Vaccarino A, et al. 8-isoprostane, prostaglandin E2, C-reactive protein and serum amyloid A as markers of inflammation and oxidative stress in antiphospholipid syndrome: a pilot study. Inflamm Res 2012; 61: 809-816.
6. Ahmed N, Babaei-Jadidi R, Howell SK, Thornalley PJ, Beisswenger PJ. Glycated and oxidized protein degradation products are indicators of fasting and postprandial hyperglycemia in diabetes. Diabetes Care 2005; 28: 2465-2471.
7. Onoue S, Ochi M, Gandy G, Seto Y, Igarashi N, Yamauchi Y, et al. High-throughout screening system for identifying phototoxic potential of drug candidates based on derivatives of reactive oxygen metabolites. Pharm Res 2010; 27: 1610-1619.
8. Trotti R, Carratelli M, Barbieri M. Performance and clinical application of a new, fast method for the detection of hydroperoxides in serum. Panminerva Med 2002; 44: 37-40.
9. Christou K, Markoulis N, Moulas AN, Pastaka C, Gourgoulianis KL. Reactive oxygen metabolites(ROMs)as an index of oxidative stress in obstructive sleep apnea patients. Sleep Breath 2003; 7: 105-110.
10. Gerardi GM, Usberti M, Martini G, Alberini A, Sugherinl L, Pompella A, et al. Plasma total antioxidant capacity in hemodialyzed patients and its relationships to other biomarkers of oxidative stress and lipid peroxidation. Clin Chem Lab Med 2002; 40: 104-110.
11. Morishita Y, Hanawa S, Chinda J, Iimura O, Tsunematsu S, Kusano E. Effects of aliskiren on blood pressure and the predictive biomarkers for cardiovascular disease in hemodialysis-dependent chronic kidney disease patients with hypertension. Hypertens Res 2011; 34: 308-313.
12. Yamagishi S, Nakamura K, Imaizumi T. Advanced glycation end products(AGEs)and diabetic vascular complications. Curr Diabetes Rev 2005; 1: 93-106.
13. Azuma K, Watada H, Niihashi M, Otsuka A, Sato F, Kawasumi M, et al. A new en face method is useful to quantitate endothelial damage in vivo. Biochem. Biophys Res Commun 2003; 309: 384-390.
14. Ceriello A, Davidson J, Menefeld M, Leiter L, Monnier L, Owens D, et al. Postprandial hyperglycemia and cardiovascular complications of diabetes: an update. Nutr Metab Cardiovasc Dis 2006; 16: 453-456.
15. Azuma K, Kawamori R, Toyofumi Y, Kitahara Y, Sato F, Shimizu T, et al. Repetitive fluctuations in blood glucose enhance monocyte adhesion to the endothelium of rat thoracic aorta. Arterioscler Thromb Vasc Biol 2006; 26: 2275-2280.
16. Fearon IM, Faux SP. Oxidative stress and cardiovascular disease: novel tools give (free) radical insight. J Mol Cell Cardiol 2009; 47: 372-381.
17. Lin CC, Su TH, Wang TS. Protein carbonylation in THP-1 cells induced by cigarette smoke extract via a copper-catalyzed pathway. Chem Res Toxicol 2009; 22: 1232-1238.
18. Van Gaal LF, Mertens IL, De Block CE. Mechanism linking obesity with cardiovascular disease. Nature 2006; 444: 875-880.
19. Ceriello A. Oxidative stress and diabetes-associated complications. Endocr Pract 2006; 12 (Suppl 1): 60-62.
20. Sakane N, Fujiwara S, Sano Y, Domichi M, Tsuzaki K, Matsuoka Y, et al. Oxidative stress, inflammation, and atherosclerosis changes in retinal arteries in the Japanese population; results from the Mima study. Endocr J 2008; 55: 485-488.
21. Aragno M, Mastrocola R, Medana C, Restivo F, Catalano MG, Pons N, et al. Up-regulation of advanced glycated products receptors in the brain of diabetic rats is prevented by antioxidant treatment. Endocrinology 2005; 146: 5561-5567.
22. Assaloni R, Ros RD, Quagliaro L, Piconi L, Maier A, Zuodar G, et al. Effects of S21403 (mitiglinide) on postprandial generation of oxidative stress and inflammation in type 2 diabetic patients. Diabetologia 2005; 48: 1919-1924.
23. Li L, Renier G. The oral anti-diabetic agent, gliclazide, inhibits oxidized LDL-mediated LOX-1 expression, metalloproteinase-9 secretion and apoptosis in human aortic endothelial cells. Atherosclerosis 2009; 204: 40-46.
24. Inukai T, Yoshida N, Wakabayashi S, Inukai Y, Matsutomo R, Takanashi K, et al. Angiotension-converting enzyme inhibitors and angiotensin II receptor blockers effectively and directly potentiate superoxide scavenging by polymorphonuclear leukocytes from patients with type 2 diabetes mellitus. Am J Med Sci 2005; 329: 222-227.
25. Inukai T, Takanashi K, Tayama K, Aso Y, Takemura Y. High glucose concentrations abolish the superoxide dismutase response of leukocytes to ascorbic acid or troglitazone in type 2 diabetes mellitus. Life Sci 2002; 70: 2391-2401.
26. Nakamura T, Sato E, Fujiwara N, Kawagoe Y, Ueda Y, Sugaya T, et al. Comparative effects of benidipine and amlodipine on proteinuria, urinary 8-OHdG, urinary L-FASP, and inflammatory and atherosclerosis markers in early-stage chronic kidney disease. Am J Med Sci 2010; 339: 157-163.